Autoclear Launches AI Threat Assist for X-Ray Security Scanners
Helps Security Teams Detect Concealed Weapons, and Other Threats
Now Used by US Schools to Improve Safety
AI Threat Assist is a proprietary software capability that uses advanced machine learning technology to analyze x-ray images and highlight potential threats for security operators by drawing a bounding box around a potential threat item found in the x-ray image. It is available now as an optional capability seamlessly integrated on Autoclear x-ray scanners. For customers that have an Autoclear x-ray system, AI Threat Assist can be installed through an in-field system upgrade.
AI Threat Assist's capabilities are continually updated to meet new school safety requirements. In response to school customer concerns regarding the use of vapes, Autoclear will be releasing a new version of AI Threat Assist in 2024 that will enable enhanced detection of vapes of all types.
AI Threat Assist is the latest addition to Autoclear's suite of proprietary software tools, such as autoMATalert and autoNARCalert, which help security operators identify potential threats and illegal or prohibited items.
"Security decision makers at schools and other locations are facing unprecedented challenges. AI Threat Assist is designed to help security personnel quickly identify potential threats concealed in bags, backpacks and purses," commented
To learn more about Autoclear's AI Threat Assist, and to schedule a demonstration, contact
About Autoclear
Headquartered in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/autoclear-launches-ai-threat-assist-for-x-ray-security-scanners-302074688.html
SOURCE Autoclear LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tenth Ward Distilling Company Celebrates 10 Years with "X Marks 10 Years" Celebration
- CMA CGM, Copersucar and Bunker One Complete First Bioethanol Bunkering of a Deep-Sea Containership in Brazil, at the Port of Santos
- FDA Approves LEQEMBI IQLIK® (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share